Senior Virology Care Specialist, Sacramento
$120k/y-$160k/y
Invivyd19 hours ago
Highlight
RemoteFull-timeSenior
Summary
Invivyd is seeking a Senior Virology Care Specialist to join their team in Sacramento, CA. The role involves developing relationships with healthcare providers and driving product demand in a fast-paced environment.
About the Role
As a Senior Virology Care Specialist, you will be responsible for building compliant relationships with healthcare providers, facilitating clinical dialogues, and developing territory business plans. You will manage your territory with a business owner mindset, deliver product presentations, and collaborate cross-functionally to support customer needs. Your role will also involve utilizing a data-driven approach to prioritize accounts and drive total selling engagements.
About You
Required:
- Bachelor’s degree required
- Sales experience in life sciences or healthcare or a related field is required
- 5+ years of experience in sales in biotech, pharmaceuticals or medical device customer-facing roles is required
- Candidates must live within the stated territory
- Able to fulfill requirement to be in the field five days a week, including overnights as required
- Ability to drive and/or fly within the territory, as required
- Proven winning attitude with a growth mindset
- Strong communication and interpersonal skills
- Demonstrated persistence, resilience, agility, and a strong work ethic
- Ability to manage time effectively and prioritize tasks
- High standards of integrity and professionalism
- Passion for making a difference in the lives of patients
Preferred:
- Coachable and eager to learn
- Strong ability to communicate clinical product information
- Demonstrated effective organizational and interpersonal skills
Benefits
- Competitive base salary ranging from $120k to $160k
- Eligibility for annual short-term and long-term incentives
- Comprehensive benefits package including health coverage
Invivyd
Invivyd, Inc. (Nasdaq: IVVD) creates medicines that are more potent and resistant to virus evolution than the human immune system. We deploy a proprietary integrated technology platform unique in the industry to assess, monitor, drug and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more. #covid19 #immunocompromised
Sacramento, CA